In addition, treatment of empagliflozin in Beclin 1 haplodeficient mice further ameliorated DNA damage (Figure 3B), cardiac fibrosis (Figure 3C), and cardiomyocyte injury (Figure 3D). This evidence concerns the gene BECN1 and fibrosis.